Ideas to Action:

Independent research for global prosperity

Publications

 

Various bottles of pills
May 1, 2019

Aggregating Demand for Pharmaceuticals is Appealing, but Pooling Is Not a Panacea

As low- and middle-income countries shift away from donor support, their challenge will be finding a way to aggregate demand in order to achieve the benefits that the pooled purchasing arrangements of vertical health programs now provide. As a first step in tackling this challenge, much can be learned from a diverse group of pooled procurement initiatives that have developed over the past 40 years in high-, middle-, and low-income countries. This note reviews the rationale and functions of these initiatives, notes their potential benefits and barriers, and draws lessons regarding how best to incorporate pooled pharmaceutical purchasing models into the design and implementation of health financing reforms in countries in transition.

Cover of Working Paper 507
April 3, 2019

The Future of Global Health Procurement: Issues around Pricing Transparency - Working Paper 507

This paper focuses on the role that price transparency may play in the efficient and effective procurement of medicines by middle- and low-income countries. Will making prices publicly available make procurement more efficient and cost-effective medicines more accessible? We conclude that transparency of the procurement process significantly lowers costs by encouraging bidders. 

Cover of Policy Paper 122
March 9, 2018

Perspective in Economic Evaluations of Healthcare Interventions in Low- and Middle-Income Countries: One Size Does Not Fit All

As developing nations are increasingly adopting economic evaluation as a means of informing their own investment decisions, new questions emerge. The right answer to the question “which perspective?” is the one tailored to these local specifics. We conclude that there is no one-size-fits-all and that the one who pays must set or have a major say in setting the perspective.

Stock photo of pills in a row
February 5, 2018

Healthcare Systems as Intelligent Payers: What Can the Global Health Community Learn from the English National Health Service?

Today, politicians are under growing pressure to squeeze more out of every dollar and guarantee greater access to better, more affordable healthcare for their citizens. In such a resource-constrained environment, wasting trillions of dollars on health every year is not viable. This note provides an overview of some of the approaches and policy options that the National Health Service in England has been using to maximise value for money.

A chart of Health Commodity Market Size in 50 Low and Middle Income Countries, 2015
December 13, 2017

An Initial Estimation of the Size of Health Commodity Markets in Low- and Middle-Income Countries

This post previews preliminary answers to one initial question: what can we say about the size and nature of health commodity markets in low- and middle-income countries? We share early insights; list the data sources we used, while also signalling others we hope to draw on going forward; and highlight our assumptions and caveats.

Stock photo of a stethoscope, a computer keyboard, and charts
November 8, 2017

Six Reasons Why the Global Fund Should Adopt Health Technology Assessment

With aid budgets shrinking and even low-income countries increasingly faced with cofinancing requirements, this is the right time for global health funders such as the Global Fund and their donors to formally introduce Health Technology Assessment (HTA), both at the central operations level and at the national or regional level in recipient countries. In this CGD Note, we explain why introducing HTA is a good idea. Specifically, we outline six benefits that the application of HTA could bring to the Global Fund, the countries it supports, and the broader global health community.

Cover of What's In What's Out factsheet
October 10, 2017

What’s In, What’s Out: Designing Benefits for Universal Health Coverage: Key Messages for Donors and Advocates

Many low- and middle-income countries aspire to universal health coverage (UHC), but for rhetoric to become reality, the health services offered must be consistent with the funds available, which may require tough tradeoffs. An explicit health benefits package—a defined list of services that are and are not subsidized—is essential in creating a sustainable UHC system.

June 11, 2012

Priority-Setting in Health: Building Institutions for Smarter Public Spending (CGD Brief)

Decisions about which type of patients receive what interventions, when, and at what cost often result from ad hoc, nontransparent processes driven more by inertia and interest groups than by science, ethics, and the public interest. Reallocating a portion of public and donor monies toward the most cost-effective health interventions would save more lives and promote health equity.

June 11, 2012

Priority-Setting in Health: Building Institutions for Smarter Public Spending

Decisions about which type of patients receive what interventions, when, and at what cost often result from ad hoc, nontransparent processes driven more by inertia and interest groups than by science, ethics, and the public interest. Reallocating a portion of public and donor monies toward the most cost-effective health interventions would save more lives and promote health equity.